LeonaBio, Inc. (LONA)

LeonaBio Statistics

Total Valuation

LeonaBio has a market cap or net worth of $81.07 million. The enterprise value is $14.08 million.

Market Cap	81.07M
Enterprise Value	14.08M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

LeonaBio has 9.39 million shares outstanding. The number of shares has increased by 108.39% in one year.

Current Share Class	9.39M
Shares Outstanding	9.39M
Shares Change (YoY)	+108.39%
Shares Change (QoQ)	+255.96%
Owned by Insiders (%)	5.67%
Owned by Institutions (%)	33.63%
Float	5.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.64
P/TBV Ratio	1.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.38, with a Debt / Equity ratio of 0.01.

Current Ratio	10.38
Quick Ratio	10.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -298.76% and return on invested capital (ROIC) is -60.47%.

Return on Equity (ROE)	-298.76%
Return on Assets (ROA)	-46.46%
Return on Invested Capital (ROIC)	-60.47%
Return on Capital Employed (ROCE)	-65.90%
Weighted Average Cost of Capital (WACC)	15.02%
Revenue Per Employee	n/a
Profits Per Employee	-$6.81M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +202.70% in the last 52 weeks. The beta is 1.98, so LeonaBio's price volatility has been higher than the market average.

Beta (5Y)	1.98
52-Week Price Change	+202.70%
50-Day Moving Average	9.60
200-Day Moving Average	6.18
Relative Strength Index (RSI)	39.37
Average Volume (20 Days)	43,182

Short Selling Information

The latest short interest is 61,955, so 0.66% of the outstanding shares have been sold short.

Short Interest	61,955
Short Previous Month	58,004
Short % of Shares Out	0.66%
Short % of Float	1.10%
Short Ratio (days to cover)	1.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.79M
Pretax Income	-129.41M
Net Income	-129.41M
EBITDA	-41.83M
EBIT	-42.79M
Earnings Per Share (EPS)	-$16.06

Balance Sheet

The company has $67.68 million in cash and $691,000 in debt, with a net cash position of $66.99 million or $7.13 per share.

Cash & Cash Equivalents	67.68M
Total Debt	691,000
Net Cash	66.99M
Net Cash Per Share	$7.13
Equity (Book Value)	49.30M
Book Value Per Share	5.25
Working Capital	62.54M

Cash Flow

Operating Cash Flow	-51.97M
Capital Expenditures	n/a
Depreciation & Amortization	960,000
Net Borrowing	n/a
Free Cash Flow	-51.97M
FCF Per Share	-$5.53

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LeonaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-108.39%
Shareholder Yield	-108.39%
Earnings Yield	-159.64%
FCF Yield	-64.10%

Analyst Forecast

The average price target for LeonaBio is $18.00, which is 108.58% higher than the current price. The consensus rating is "Buy".

Price Target	$18.00
Price Target Difference	108.58%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 18, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2